Skip to main content
SpringerLink
Log in

Molekulare Mechanismen der Wachstumswirkung des IGF-Systems

  • Chapter
Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen

Part of the book series: Molekulare Medizin ((MOLMED))

  • 1137 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

1.5.7 Literatur

  • Abuzzahab MJ, Schneider A, Goddard A et al. (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349: 2211–2222

    Article  PubMed  CAS  Google Scholar 

  • Adesanya OO, Zhou J, Samathanam C, Powell-Braxton L, Bondy CA (1999) Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc Natl Acad Sci USA 96: 3287–3291

    Article  PubMed  CAS  Google Scholar 

  • Andress DL (2001) IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice. Am J Physiol Endocrinol Metab 281: E283–E288

    PubMed  CAS  Google Scholar 

  • Andress DL, Loop SM, Zapf J, Kiefer MC (1993) Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 195: 25–30

    Article  PubMed  CAS  Google Scholar 

  • Attwell S, Mills J, Troussard A, Wu C, Dedhar S (2003) Integration of cell attachment, cytoskeletal localization, and signaling by integrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressor PTEN. Mol Biol Cell 14: 4813–4825

    Article  PubMed  CAS  Google Scholar 

  • August GP, Nissley SP, Kasuga M, Lee L, Greenstein L, Rechler MM (1983) Purification of an insulin-like growth factor II receptor from rat chondrosarcoma cells. J Biol Chem 258: 9033–9036

    PubMed  CAS  Google Scholar 

  • Bach LA, Thotakura NR, Rechler MM (1992) Human insulin-like growth factor binding protein-6 is O-glycosylated. Biochem Biophys Res Commun 186: 301–307

    Article  PubMed  CAS  Google Scholar 

  • Bai H, Pollman MJ, Inishi Y, Gibbons GH (1999) Regulation of vascular smooth muscle cell apoptosis. Modulation of BAD by a phosphatidylinositol 3-kinase-dependent pathway. Circ Res 85: 229–237

    PubMed  CAS  Google Scholar 

  • Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73–82

    Article  PubMed  CAS  Google Scholar 

  • Balana ME, Labriola L, Salatino M, Movsichoff F, Peters G, Charreau EH, Elizalde PV (2001) Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene 20: 34–47

    Article  PubMed  CAS  Google Scholar 

  • Barbieri M, Bonafe M, Franceschi C, Paolisso G (2003) Insulin/IGF-I-signaling pathway: An evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 285: E1064–E1071

    PubMed  CAS  Google Scholar 

  • Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332: F105–F126

    PubMed  CAS  Google Scholar 

  • Baserga R, Peruzzi F, Reiss K (2003) The IGF-1 receptor in cancer biology. Int J Cancer 107: 873–877

    Article  PubMed  CAS  Google Scholar 

  • Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72: 1189–1193

    PubMed  CAS  Google Scholar 

  • Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL, D’Ercole AJ (1990) Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127: 1033–1040

    PubMed  CAS  Google Scholar 

  • Beitner-Johnson D, Blakesley VA, Shen-Orr Z, Jimenez M, Stannard B, Wang LM, Pierce J, LeRoith D (1996) The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling. J Biol Chem 271: 9287–9290

    Article  PubMed  CAS  Google Scholar 

  • Besnard V, Corroyer S, Trugnan G, Chadelat K, Nabeyrat E, Cazals V, Clement A (2001) Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. Biochim Biophys Acta 1538: 47–58

    Article  PubMed  CAS  Google Scholar 

  • Bienvenu G, Seurin D, Grellier P et al. (2004) IGFBP-6 transgenic mice: Post-natal growth, brain development and reproduction abnormalities. Endocrinology 145: 2412–2420

    Article  PubMed  CAS  Google Scholar 

  • Birger Y, Shemer R, Perk J, Razin A (1999) The imprinting box of the mouse Igf2r gene. Nature 397: 84–88

    Article  PubMed  CAS  Google Scholar 

  • Bonifacino JS (2004) The GGA proteins: Adaptors on the move. Nat Rev Mol Cell Biol 5: 23–32

    Article  PubMed  CAS  Google Scholar 

  • Braulke T (1999) Type-2 IGF receptor: A multi-ligand binding protein. Horm Metab Res 31: 242–246

    PubMed  CAS  Google Scholar 

  • Brunet A, Bonni A, Zigmond MJ et al. (1999) AKT promotes cell survival by phosphorylating and inhibiting a Fork-head transcription factor. Cell 96: 857–868

    Article  PubMed  CAS  Google Scholar 

  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646–649

    Article  PubMed  CAS  Google Scholar 

  • Burgaud JL, Resnicoff M, Baserga R (1995) Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 214: 475–481

    Article  PubMed  CAS  Google Scholar 

  • Byrd JC, Park JH, Schaffer BS, Garmroudi F, MacDonald RG (2000) Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor. J Biol Chem 275: 18647–18656

    Article  PubMed  CAS  Google Scholar 

  • Canfield WM, Kornfeld S (1989) The chicken liver cation-independent mannose 6-phosphate receptor lacks the high affinity binding site for insulin-like growth factor II. J Biol Chem 264: 7100–7103

    PubMed  CAS  Google Scholar 

  • Chakravarti A, Loeffler JS, Dyson NJ (2002) Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Cancer Res 62: 200–207

    PubMed  CAS  Google Scholar 

  • Chen HJ, Yuan J, Lobel P (1997) Systematic mutational analysis of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor cytoplasmic domain. An acidic cluster containing a key aspartate is important for function in lysosomal enzyme sorting. J Biol Chem 272: 7003–7012

    Article  PubMed  CAS  Google Scholar 

  • Christofori G, Naik P, Hanahan D (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414–418

    Article  PubMed  CAS  Google Scholar 

  • Clairmont KB, Czech MP (1989) Chicken and Xenopus mannose 6-phosphate receptors fail to bind insulin-like growth factor II. J Biol Chem 264: 16390–16392

    PubMed  CAS  Google Scholar 

  • Clemmons DR (2002) Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5: 181–183

    Article  PubMed  CAS  Google Scholar 

  • Coelho CM, Leevers SJ (2000) Do growth and cell division rates determine cell size in multicellular organisms? J Cell Sci 113 (Pt 17): 2927–2934

    PubMed  CAS  Google Scholar 

  • Conlon I, Raff M (1999) Size control in animal development. Cell 96: 235–244

    Article  PubMed  CAS  Google Scholar 

  • Conover CA (1991) Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: Evidence for processing of cell-bound IGFBP-3. Endocrinology 129: 3259–3268

    Article  PubMed  CAS  Google Scholar 

  • Conover CA, Kiefer MC (1993) Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 76: 1153–1159

    Article  PubMed  CAS  Google Scholar 

  • Conover CA, Liu F, Powell D, Rosenfeld RG, Hintz RL (1989) Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation. J Clin Invest 83: 852–859

    PubMed  CAS  Google Scholar 

  • Coppola D, Ferber A, Miura M, Sell C, D’Ambrosio C, Rubin R, Baserga R (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14: 4588–4595

    PubMed  CAS  Google Scholar 

  • Coverley JA, Martin JL, Baxter RC (2000) The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 141: 564–570

    Article  PubMed  CAS  Google Scholar 

  • D’Ambrosio C, Ferber A, Resnicoff M, Baserga R (1996) A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res 56: 4013–4020

    PubMed  CAS  Google Scholar 

  • D’Ercole AJ, Dai Z, Xing Y et al. (1994) Brain growth retardation due to the expression of human insulin like growth factor binding protein-1 in transgenic mice: An in vivo model for the analysis of igf function in the brain. Brain Res Dev Brain Res 82: 213–222

    Article  PubMed  CAS  Google Scholar 

  • De Leon DD, Terry C, Asmerom Y, Nissley P (1996) Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells. Endocrinology 137: 1851–1859

    Article  PubMed  Google Scholar 

  • De Meyts P, Whittaker J (2002) Structural biology of insulin and IGF1 receptors: Implications for drug design. Nat Rev Drug Discov 1: 769–783

    Article  PubMed  CAS  Google Scholar 

  • De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11:447–449

    Article  PubMed  Google Scholar 

  • DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78–80

    Article  PubMed  CAS  Google Scholar 

  • Dell’Angelica EC, Payne GS (2001) Intracellular cycling of lysosomal enzyme receptors: Cytoplasmic tails’ tales. Cell 106: 395–398

    Article  PubMed  CAS  Google Scholar 

  • Dennis PA, Rifkin DB (1991) Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580–584

    Article  PubMed  CAS  Google Scholar 

  • Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E (2002) Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 143: 3955–3962

    Article  PubMed  CAS  Google Scholar 

  • Diehl D, Hoeflich A, Wolf E, Lahm H (2004) Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanisms. Cancer Res 64: 1600–1603

    Article  PubMed  CAS  Google Scholar 

  • Dupont J, Karas M, LeRoith D (2000) The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J Biol Chem 275: 35893–35901

    Article  PubMed  CAS  Google Scholar 

  • Dupont J, Karas M, LeRoith D (2003) The cyclin-dependent kinase inhibitor p21CIP/WAF is a positive regulator of insulin-like growth factor I-induced cell proliferation in MCF-7 human breast cancer cells. J Biol Chem 278: 37256–37264

    Article  PubMed  CAS  Google Scholar 

  • Dupont J, LeRoith D (2001) Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: New insights into their synergistic effects. Mol Pathol 54: 149–154

    Article  PubMed  CAS  Google Scholar 

  • Eckstein F, Pavicic T, Nedbal S et al. (2002) Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat Embryol (Berl) 206: 139–148

    Article  CAS  Google Scholar 

  • Efstratiadis A (1998) Genetics of mouse growth. Int J Dev Biol 42: 955–976

    PubMed  CAS  Google Scholar 

  • Essers MA, Vries-Smits de LM, Barker N, Polderman PE, Burgering BM, Korswagen HC (2005) Functional interaction between beta-catein and FOXO in oxidative stress signaling. Science 308(5725): 1181–1184

    Article  PubMed  CAS  Google Scholar 

  • Fan J, Wojnar MM, Theodorakis M, Lang CH (1996) Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am J Physiol 270: R621–R629

    PubMed  CAS  Google Scholar 

  • Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824–854

    Article  PubMed  CAS  Google Scholar 

  • Firth SM, Ganeshprasad U, Poronnik P, Cook DI, Baxter RC (1999) Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3. Protein Expr Purif 16: 202–211

    Article  PubMed  CAS  Google Scholar 

  • Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM (1997) Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs)-3,-5, and-6 inhibit IGFBP-4 degradation. Endocrinology 138: 2280–2285

    Article  PubMed  CAS  Google Scholar 

  • Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3 K/Akt and apoptosis: Size matters. Oncogene 22: 8983–8998

    Article  PubMed  CAS  Google Scholar 

  • Frattali AL, Pessin JE (1993) Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors. J Biol Chem 268: 7393–7400

    PubMed  CAS  Google Scholar 

  • Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE (2003) Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). J Biol Chem 278: 13325–13332

    Article  PubMed  CAS  Google Scholar 

  • Gay E, Seurin D, Babajko S, Doublier S, Cazillis M, Binoux M(1997) Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante-and perinatal mortality and postnatal growth. Endocrinology 138: 2937–2947

    Article  PubMed  CAS  Google Scholar 

  • Ghosh P, Dahms NM, Kornfeld S (2003) Mannose 6-phosphate receptors: New twists in the tale. Nat Rev Mol Cell Biol 4: 202–212

    Article  PubMed  CAS  Google Scholar 

  • Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285: 1028–1032

    Article  PubMed  CAS  Google Scholar 

  • Gilmore AP, Valentijn AJ, Wang P et al. (2002) Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J Biol Chem 277: 27643–27650

    Article  PubMed  CAS  Google Scholar 

  • Gray SG, Stenfeldt MI, De Meyts P (2003) The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy? Horm Metab Res 35: 857–871

    Article  PubMed  CAS  Google Scholar 

  • Guler HP, Zapf J, Schmid C, Froesch ER (1989) Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121: 753–758

    PubMed  CAS  Google Scholar 

  • Guvakova MA, Surmacz E (1999) The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin. Exp Cell Res 251: 244–255

    Article  PubMed  CAS  Google Scholar 

  • Hamelers IH, Van Schaik RF, Teeffelen HA van, Sussenbach JS, Steenbergh PH (2002) Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells. Exp Cell Res 273: 107–117

    Article  PubMed  CAS  Google Scholar 

  • Hamet P, Tremblay J (2003) Genes of aging. Metabolism 52:5–9

    Article  PubMed  CAS  Google Scholar 

  • Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL (1996) M6P/IGF2 receptor: A candidate breast tumor suppressor gene. Oncogene 12: 2003–2009

    PubMed  CAS  Google Scholar 

  • He W, Craparo A, Zhu Y, O’Neill TJ, Wang LM, Pierce JH, Gustafson TA (1996) Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J Biol Chem 271: 11641–11645

    Article  PubMed  CAS  Google Scholar 

  • Heck S, Lezoualc’h F, Engert S, Behl C (1999) Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem 274: 9828–9835

    Article  PubMed  CAS  Google Scholar 

  • Heron-Milhavet L, LeRoith D (2002) Insulin-like growth factor I induces MDM 2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage. J Biol Chem 277: 15600–15606

    Article  PubMed  CAS  Google Scholar 

  • Hess P, Pihan G, Sawyers CL, Flavell RA, Davis RJ (2002) Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet 32: 201–205

    Article  PubMed  CAS  Google Scholar 

  • Hoeck WG, Mukku VR (1994) Identification of the major sites of phosphorylation in IGF binding protein-3. J Cell Biochem 56: 262–273

    Article  PubMed  CAS  Google Scholar 

  • Hoeflich A, Bunger L, Nedbal S et al. (2004) Growth selection in mice reveals conserved and redundant expression patterns of the insulin-like growth factor system. Gen Comp Endocrinol 136: 248–259

    Article  PubMed  CAS  Google Scholar 

  • Hoeflich A, Wu M, Mohan S et al. (1999) Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140: 5488–5496

    Article  PubMed  CAS  Google Scholar 

  • Hoeflich A, Weber MM, Fisch T et al. (2002) Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF-I excess on adrenocortical cells in vivo. FASEB J 16: 1721–1731

    Article  PubMed  CAS  Google Scholar 

  • Holzenberger M, Dupont J, Ducos B et al. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182–187

    Article  PubMed  CAS  Google Scholar 

  • Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ (2001) Activation of AKT (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21: 2203–2212

    Article  PubMed  CAS  Google Scholar 

  • Irving JA, Lala PK (1995) Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res 217:419–427

    Article  PubMed  CAS  Google Scholar 

  • Isaksson OG, Jansson JO, Gause IA (1982) Growth hormone stimulates longitudinal bone growth directly. Science 216:1237–1239

    PubMed  CAS  Google Scholar 

  • Isaksson OG, Lindahl A, Nilsson A, Isgaard J (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8: 426–438

    PubMed  CAS  Google Scholar 

  • Jansen M, Schaik FM van, Tol H van, Van den Brande JL, Sussenbach JS (1985) Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett 179: 243–246

    Article  PubMed  CAS  Google Scholar 

  • Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu RT, Havemann K (1997) Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138: 1767–1770

    Article  PubMed  CAS  Google Scholar 

  • Javelaud D, Besancon F (2002) Inactivation of p21WAFl sensitizes cells to apoptosis via an increase of both pl4ARF and p53 levels and an alteration of the Bax/BCL-2 ratio. J Biol Chem 277: 37949–37954

    Article  PubMed  CAS  Google Scholar 

  • Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3–34

    Article  PubMed  CAS  Google Scholar 

  • Jones JI, D’Ercole AJ, Camacho-Hubner C, Clemmons DR (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481–7485

    Article  PubMed  CAS  Google Scholar 

  • Jones JI, Gockerman A, Busby WH Jr, Wright G, Clemmons DR (1993) Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90: 10553–10557

    Article  PubMed  CAS  Google Scholar 

  • Kajantie E (2003) Insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1 and postnatal growth in very-low-birth-weight infants. Horm Res 60Suppl 3: 124–130

    Article  PubMed  CAS  Google Scholar 

  • Kalebic T, Blakesley V, Slade C, Plasschaert S, LeRoith D, Helman LJ (1998) Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R. Int J Cancer 76: 223–227

    Article  PubMed  CAS  Google Scholar 

  • Kaleko M, Rutter WJ, Miller AD (1990) Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10: 464–473

    PubMed  CAS  Google Scholar 

  • Kiess W, Haskell JF, Lee L et al. (1987) An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. J Biol Chem 262: 12745–12751

    PubMed  CAS  Google Scholar 

  • Kiess W, Thomas CL, Greenstein LA et al. (1989) Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of beta-galactosidase and the binding of beta-galactosidase to purified IGF-II/mannose 6-phosphate receptor. J Biol Chem 264: 4710–4714

    PubMed  CAS  Google Scholar 

  • Killian JK, Nolan CM, Wylie AA, Li T, Vu TH, Hoffman AR, Jirtle RL (2001) Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary. Hum Mol Genet 10: 1721–1728

    Article  PubMed  CAS  Google Scholar 

  • Kodama Y, Baxter RC, Martin JL (2002) Insulin-like growth factor-I inhibits cell growth in the α549 non-small lung cancer cell line. Am J Respir Cell Mol Biol 27: 336–344

    PubMed  CAS  Google Scholar 

  • Kornfeld S (1992) Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61: 307–330

    Article  PubMed  CAS  Google Scholar 

  • Kreiling JL, Byrd JC, Deisz RJ, Mizukami IF, Todd RF III, MacDonald RG (2003) Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR. J Biol Chem 278: 20628–20637

    Article  PubMed  CAS  Google Scholar 

  • Kubota N, Tobe K, Terauchi Y et al. (2000) Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49: 1880–1889

    PubMed  CAS  Google Scholar 

  • Kuemmerle JF (2003) IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3 K, PDK-1, and p70S6 kinase. Am J Physiol Gastrointest Liver Physiol 284: G411–G422

    PubMed  CAS  Google Scholar 

  • Kuemmerle JF, Zhou H, Bowers JG (2004) IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins. Am J Physiol Gastrointest Liver Physiol 286: G412–G419

    Article  PubMed  CAS  Google Scholar 

  • Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC (1994) Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58: 452–459

    PubMed  CAS  Google Scholar 

  • Lalou C, Lassarre C, Binoux M (1996) A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137: 3206–3212

    Article  PubMed  CAS  Google Scholar 

  • Lamothe B, Bucchini D, Jami J, Joshi RL (1995) Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system. FEBS Lett 373: 51–55

    Article  PubMed  CAS  Google Scholar 

  • Lawlor MA, Mora A, Ashby PR et al. (2002) Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21: 3728–3738

    Article  PubMed  CAS  Google Scholar 

  • LeRoith D (2003) The insulin-like growth factor system. Exp Diabesity Res 4: 205–212

    Google Scholar 

  • LeRoith D, Bondy C, Yakar S, Liu JL, Butler A (2001) The somatomedin hypothesis: 2001. Endocr Rev 22: 53–74

    Article  CAS  Google Scholar 

  • Leal SM, Huang SS, Huang JS (1999) Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells. J Biol Chem 274: 6711–6717

    Article  PubMed  CAS  Google Scholar 

  • Leverrier Y, Thomas J, Mathieu AL, Low W, Blanquier B, Marvel J (1999) Role of PI3-kinase in BCL-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ 6: 290–296

    Article  PubMed  CAS  Google Scholar 

  • Lippman ME, Dickson RB, Gelmann EP et al. (1987) Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem 35: 1–16

    Article  PubMed  CAS  Google Scholar 

  • Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P (2000) Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 275: 33607–33613

    Article  PubMed  CAS  Google Scholar 

  • Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59–72

    Article  PubMed  CAS  Google Scholar 

  • Lopaczynski W, Harris S, Nissley P (1993) Insulin-like growth factor-I (IGF-I) dependent phosphorylation of the IGF-I receptor in MG-63 cells. Regul Pept 48: 207–216

    Article  PubMed  CAS  Google Scholar 

  • Ludwig T, Eggenschwiler J, Fisher P, D’Ercole AJ, Davenport ML, Efstratiadis A (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev Biol 177: 517–535

    Article  PubMed  CAS  Google Scholar 

  • Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229: 141–162

    Article  PubMed  CAS  Google Scholar 

  • Macaulay VM, Everard MJ, Teale JD, Trott PA, Van Wyk JJ, Smith IE, Millar JL (1990) Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res 50: 2511–2517

    PubMed  CAS  Google Scholar 

  • Maile LA, Badley-Clarke J, Clemmons DR (2003) The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Mol Biol Cell 14: 3519–3528

    Article  PubMed  CAS  Google Scholar 

  • Mannhardt B, Weinzimer SA, Wagner M, Fiedler M, Cohen P, Jansen-Durr P, Zwerschke W (2000) Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol 20: 6483–6495

    Article  PubMed  CAS  Google Scholar 

  • Marinaro JA, Neumann GM, Russo VC, Leeding KS, Bach LA (2000) O-Glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Eur J Biochem 267: 5378–5386

    Article  PubMed  CAS  Google Scholar 

  • Martin JL, Baxter RC (1986) Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 261: 8754–8760

    PubMed  CAS  Google Scholar 

  • Martin JL, Ballesteros M, Baxter RC (1992) Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 131:1703–1710

    Article  PubMed  CAS  Google Scholar 

  • Marzella L, Glaumann H (1983) Biogenesis, translocation, and function of lysosomal enzymes. Int Rev Exp Pathol 25: 239–278

    PubMed  CAS  Google Scholar 

  • Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F (1990) Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4: 1327–1335

    Article  PubMed  CAS  Google Scholar 

  • McMullen JR, Shioi T, Huang WY et al. (2004) The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem 279: 4782–4793

    Article  PubMed  CAS  Google Scholar 

  • Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by RAS and PKB through p27KIP1. Nature 404:782–787

    Article  PubMed  CAS  Google Scholar 

  • Mishra S, Murphy LJ (2003) Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding. Endocrinology 144: 4042–4050

    Article  PubMed  CAS  Google Scholar 

  • Morrione A, Valentinis B, Li S, Ooi JY, Margolis B, Baserga R (1996) GRB10: A new substrate of the insulin-like growth factor I receptor. Cancer Res 56: 3165–3167

    PubMed  CAS  Google Scholar 

  • Mulligan C, Rochford J, Denyer G et al. (2002) Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J Biol Chem 277: 42480–42487

    Article  PubMed  CAS  Google Scholar 

  • Murray SA, Zheng H, Gu L, Jim Xiao ZX (2003) IGF-1 activates p21 to inhibit UV-induced cell death. Oncogene 22: 1703–1711

    Article  PubMed  CAS  Google Scholar 

  • Musaro A, McCullagh K, Paul A et al. (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195–200

    Article  PubMed  CAS  Google Scholar 

  • Napoli C, Martin-Padura I, Nigris F de et al. (2003) Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100: 2112–2116

    Article  PubMed  CAS  Google Scholar 

  • Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381–395

    Article  PubMed  CAS  Google Scholar 

  • Nickerson T, Huynh H, Pollak M (1997) Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem Biophys Res Commun 237: 690–693

    Article  PubMed  CAS  Google Scholar 

  • Ohlsson C, Kley N, Werner H, LeRoith D (1998) p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Spl. Endocrinology 139: 1101–1107

    Article  PubMed  CAS  Google Scholar 

  • Oka Y, Rozek LM, Czech MP (1985) Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem 260: 9435–9442

    PubMed  CAS  Google Scholar 

  • Okubo Y, Blakesley VA, Stannard B, Gutkind S, LeRoith D (1998) Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem 273: 25961–25966

    Article  PubMed  CAS  Google Scholar 

  • Oppenheimer CL, Czech MP (1983) Purification of the type II insulin-like growth factor receptor from rat placenta. J Biol Chem 258: 8539–8542

    PubMed  CAS  Google Scholar 

  • Parker A, Rees C, Clarke J, Busby WH Jr, Clemmons DR (1998) Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell 9: 2383–2392

    PubMed  CAS  Google Scholar 

  • Pereira JJ, Meyer T, Docherty SE et al. (2004) Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res 64: 977–984

    Article  PubMed  CAS  Google Scholar 

  • Perks CM, Bowen S, Gill ZP, Newcomb PV, Holly JM (1999) Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J Cell Biochem 75: 652–664

    Article  PubMed  CAS  Google Scholar 

  • Piwien-Pilipuk G, Huo JS, Schwartz J (2002) Growth hormone signal transduction. J Pediatr Endocrinol Metab 15: 771–786

    PubMed  CAS  Google Scholar 

  • Polychronakos C (1993) Parental imprinting of the genes for IGF-II and its receptor. Adv Exp Med Biol 343: 189–203

    PubMed  CAS  Google Scholar 

  • Potter CJ, Xu T (2001) Mechanisms of size control. Curr Opin Genet Dev 11: 279–286

    Article  PubMed  CAS  Google Scholar 

  • Puertollano R, Aguilar RC, Gorshkova I, Crouch RJ, Bonifacino JS (2001) Sorting of mannose 6-phosphate receptors mediated by the GGAs. Science 292: 1712–1716

    Article  PubMed  CAS  Google Scholar 

  • Purdom S, Chen QM (2003) Linking oxidative stress and genetics of aging with p66Shc signaling and forkhead transcription factors. Biogerontology 4: 181–191

    Article  PubMed  CAS  Google Scholar 

  • Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S (1997) Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272: 13937–13944

    Article  PubMed  CAS  Google Scholar 

  • Rajah R, Lee KW, Cohen P (2002) Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of BCL-2 phosphorylation. Cell Growth Differ 13: 163–171

    PubMed  CAS  Google Scholar 

  • Rajkumar K, Dheen ST, Murphy LJ (1996a) Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice. Am J Physiol 270: E565–E571

    PubMed  CAS  Google Scholar 

  • Rajkumar K, Dheen T, Krsek M, Murphy LJ (1996b) Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 137: 1258–1264

    Article  PubMed  CAS  Google Scholar 

  • Rajkumar K, Krsek M, Dheen ST, Murphy LJ (1996 c) Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98: 1818–1825

    Article  PubMed  CAS  Google Scholar 

  • Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR (2002) A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81–91

    Article  PubMed  CAS  Google Scholar 

  • Rinderknecht E, Humbel RE (1976) Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. Proc Natl Acad Sci USA 73: 4379–4381

    Article  PubMed  CAS  Google Scholar 

  • Rinderknecht E, Humbel RE (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253: 2769–2776

    PubMed  CAS  Google Scholar 

  • Rotwein P (1991) Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5: 3–18

    PubMed  CAS  Google Scholar 

  • Rotwein P, Pollock KM, Didier DK, Krivi GG (1986) Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 261: 4828–4832

    PubMed  CAS  Google Scholar 

  • Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM (2000) Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 275: 22583–22589

    Article  PubMed  CAS  Google Scholar 

  • Russo VC, Bach LA, Fosang AJ, Baker NL, Werther GA (1997) Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 138: 4858–4867

    Article  PubMed  CAS  Google Scholar 

  • Russo VC, Rekaris G, Baker NL, Bach LA, Werther GA (1999) Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells. Endocrinology 140: 3082–3090

    Article  PubMed  CAS  Google Scholar 

  • Salih DA, Tripathi G, Holding C et al. (2004) Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci USA 101: 4314–4319

    Article  PubMed  CAS  Google Scholar 

  • Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49: 825–836

    PubMed  CAS  Google Scholar 

  • Sara VR, Carlsson-Skwirut C, Andersson C, Hall E, Sjogren B, Holmgren A, Jornvall H (1986) Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci USA 83: 4904–4907

    Article  PubMed  CAS  Google Scholar 

  • Sasaoka T, Rose DW, Jhun BH, Saltiel AR, Draznin B, Olefsky JM (1994) Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem 269: 13689–13694

    PubMed  CAS  Google Scholar 

  • Schedlich LJ, Nilsen T, John AP, Jans DA, Baxter RC (2003) Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology 144: 1984–1993

    Article  PubMed  CAS  Google Scholar 

  • Schnyder B, Lahm H, Woerly G, Odartchenko N, Ryffel B, Car BD (1996) Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1. Biochem J 315 (Pt 3): 767–774

    PubMed  CAS  Google Scholar 

  • Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90: 11217–11221

    Article  PubMed  CAS  Google Scholar 

  • Silha JV, Murphy LJ (2002) Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143: 3711–3714

    Article  PubMed  CAS  Google Scholar 

  • Sjogren K, Liu JL, Blad K et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96: 7088–7092

    Article  PubMed  CAS  Google Scholar 

  • Song SW, Fuller GN, Khan A et al. (2003) IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Acad Sci USA 100: 13970–13975

    Article  PubMed  CAS  Google Scholar 

  • Stoger R, Kubicka P, Liu CG, Kafri T, Razin A, Cedar H, Barlow DP (1993) Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73: 61–71

    Article  PubMed  CAS  Google Scholar 

  • Sun XJ, Wang LM, Zhang Y et al. (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173–177

    Article  PubMed  CAS  Google Scholar 

  • Tamemoto H, Kadowaki T, Tobe K et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372: 182–186

    Article  PubMed  CAS  Google Scholar 

  • Tong PY, Gregory W, Kornfeld S (1989) Ligand interactions of the cation-independent mannose 6-phosphate receptor. The stoichiometry of mannose 6-phosphate binding. J Biol Chem 264: 7962–7969

    PubMed  CAS  Google Scholar 

  • Tonner E, Barber MC, Travers MT, Logan A, Flint DJ (1997) Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 138: 5101–5107

    Article  PubMed  CAS  Google Scholar 

  • Tonner E, Barber MC, Allan GJ, Beattie J, Webster J, Whitelaw CB, Flint DJ (2002) Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129: 4547–4557

    PubMed  CAS  Google Scholar 

  • Troussard AA, Mawji NM, Ong C, Mui A, Arnaud R, Dedhar S (2003) Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 278: 22374–22378

    Article  PubMed  CAS  Google Scholar 

  • Twigg SM, Kiefer MC, Zapf J, Baxter RC (1998) Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain. J Biol Chem 273: 28791–28798

    Article  PubMed  CAS  Google Scholar 

  • Valentinis B, Morrione A, Taylor SJ, Baserga R (1997) Insulin-like growth factor I receptor signaling in transformation by src oncogenes. Mol Cell Biol 17: 3744–3754

    PubMed  CAS  Google Scholar 

  • VanderKuur J, Allevato G, Billestrup N, Norstedt G, Carter-Su C (1995) Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with GRB2. J Biol Chem 270: 7587–7593

    Article  PubMed  CAS  Google Scholar 

  • Wang H, Wang H, Shen W et al. (2003) Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 63: 4315–4321

    PubMed  CAS  Google Scholar 

  • Wang J, Niu W, Witte DP et al. (1998a) Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 139: 2605–2614

    Article  PubMed  CAS  Google Scholar 

  • Wang L, Ma W, Markovich R, Lee WL, Wang PH (1998b) Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 139: 1354–1360

    Article  PubMed  CAS  Google Scholar 

  • Wang ZQ, Fung MR, Barlow DP, Wagner EF (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372: 464–467

    Article  PubMed  CAS  Google Scholar 

  • Wheatcroft SB, Kearney MT, Shah AM, Grieve DJ, Williams IL, Miell JP, Crossey PA (2003) Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1. Diabetes 52: 2075–2082

    PubMed  CAS  Google Scholar 

  • Wilden PA, Treadway JL, Morrison BD, Pessin JE (1989) IGF-1-dependent subunit communication of the IGF-1 holoreceptor: interactions between alpha beta heterodimeric receptor halves. Biochemistry 28: 9734–9740

    Article  PubMed  CAS  Google Scholar 

  • Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, Paraskeva C (2000) Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 60: 22–27

    PubMed  CAS  Google Scholar 

  • Winn N, Paul A, Musaro A, Rosenthal N (2002) Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease. Cold Spring Harb Symp Quant Biol 67: 507–518

    Article  PubMed  CAS  Google Scholar 

  • Wolf E, Hoeflich A, Lahm H (1998) What is the function of IGF-II in postnatal life? Answers from transgenic mouse models. Growth Horm IGF Res 8: 185–193

    Article  PubMed  CAS  Google Scholar 

  • Wolf E, Kramer R, Blum WF, Foll J, Brem G (1994) Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: Endocrine changes and effects on body and organ growth. Endocrinology 135: 1877–1886

    Article  PubMed  CAS  Google Scholar 

  • Wood TL, Rogler L, Streck RD, Cerro J, Green B, Grewal A, Pintar JE (1993) Targeted disruption of IGFBP-2 gene. Growth Regul 3: 5–8

    PubMed  CAS  Google Scholar 

  • Wood TL, Rogler LE, Czick ME, Schuller AG, Pintar JE (2000) Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. Mol Endocrinol 14: 1472–1482

    Article  PubMed  CAS  Google Scholar 

  • Wylie AA, Pulford DJ, McVie-Wylie AJ et al. (2003) Tissue-specific inactivation of murine M6P/IGF2R. Am J Pathol 162: 321–328

    PubMed  CAS  Google Scholar 

  • Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, Le-Roith D (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96: 7324–7329

    Article  PubMed  CAS  Google Scholar 

  • Yam A, Hyun T, Li W (2001) Characterization of insulin-like growth factor I (IGF-I) receptor mutants for their effects on IGF-I-and interleukin 4-mediated DNA synthesis of 32D cells. J Biol Chem 276: 24409–24413

    Article  PubMed  CAS  Google Scholar 

  • Zadeh SM, Binoux M (1997) The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology 138: 3069–3072

    Article  PubMed  CAS  Google Scholar 

  • Zaina S, Squire S (1998) The soluble type 2 insulin-like growth factor (IGF-II) receptor reduces organ size by IGF-II-mediated and IGF-II-independent mechanisms. J Biol Chem 273: 28610–28616

    Article  PubMed  CAS  Google Scholar 

  • Zaina S, Newton RV, Paul MR, Graham CF (1998) Local reduction of organ size in transgenic mice expressing a soluble insulin-like growth factor II/mannose-6-phosphate receptor. Endocrinology 139: 3886–3895

    Article  PubMed  CAS  Google Scholar 

  • Zaina S, Pettersson L, Ahren B et al. (2002) Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem 277: 4505–4511

    Article  PubMed  CAS  Google Scholar 

  • Zaina S, Pettersson L, Thomsen AB, Chai CM, Qi Z, Thyberg J, Nilsson J (2003) Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology 144: 2695–2703

    Article  PubMed  CAS  Google Scholar 

  • Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B (1998) Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 17: 5085–5094

    Article  PubMed  CAS  Google Scholar 

  • Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL (2003) Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18: 836–843

    Article  PubMed  CAS  Google Scholar 

  • Zhou R, Diehl D, Hoeflich A, Lahm H, Wolf E (2003) IGF-binding protein-4: biochemical characteristics and functional consequences. J Endocrinol 178: 177–193

    Article  PubMed  CAS  Google Scholar 

  • Zhou R, Flaswinkel H, Schneider M, Lahm H, Hoeflich A, Wanke R, Wolf E (2004) Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice. J Mol Endocrinol 32: 349–364

    Article  PubMed  CAS  Google Scholar 

  • Zhu T, Goh EL, LeRoith D, Lobie PE (1998a) Growth hormone stimulates the formation of a multiprotein signaling complex involving pl30(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem 273: 33864–33875

    Article  PubMed  CAS  Google Scholar 

  • Zhu T, Goh EL, Lobie PE (1998b) Growth hormone stimulates the tyrosine phosphorylation and association of pl25 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription. J Biol Chem 273: 10682–10689

    Article  PubMed  CAS  Google Scholar 

  • Zhu Y, Doray B, Poussu A, Lehto VP, Kornfeld S (2001) Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor. Science 292: 1716–1718

    Article  PubMed  CAS  Google Scholar 

  • Zumstein PP, Luthi C, Humbel RE (1985) Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci USA 82: 3169–3172

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lehrstuhl für Molekulare Tierzucht und Biotechnologie Genzentrum, Ludwig-Maximilians-Universität München, Feodor-Lynen-Straße 25, 81377, München

    PD Dr. Andreas Hoeflich, PD Dr. Harald Lahm & Prof. Dr. Eckhard Wolf

Authors
  1. PD Dr. Andreas Hoeflich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PD Dr. Harald Lahm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. Eckhard Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charité — Universitätsmedizin Berlin, Schumannstr. 20/21, 10117, Berlin

    Detlev Ganten (Der Vorstandsvorsitzende (CEO) (Der Vorstandsvorsitzende (CEO)

  2. Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Straße 10, 13122, Berlin-Buch

    Klaus Ruckpaul

  3. Charité Campus Mitte Institut für Experimentelle Endokrinologie, Charité — Universitätsmedizin Berlin, Schumannstraße 20/21, 10117, Berlin

    Josef Köhrle

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hoeflich, A., Lahm, H., Wolf, E. (2006). Molekulare Mechanismen der Wachstumswirkung des IGF-Systems. In: Ganten, D., Ruckpaul, K., Köhrle, J. (eds) Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28782-5_5

Download citation

Publish with us

Policies and ethics

Search

Navigation